Standard Dose of Magnesium Glycinate
For general adult supplementation, start with 200-400 mg of elemental magnesium daily from magnesium glycinate, which corresponds to the Recommended Dietary Allowance of 320 mg for women and 420 mg for men. 1
Recommended Dosing Strategy
Begin at the recommended daily allowance (320 mg elemental magnesium for women; 420 mg for men) and increase gradually according to tolerance. 1 The Institute of Medicine's Dietary Reference Intake guidelines established these values as the standard daily dose for magnesium supplementation. 1
Dose Titration Approach
- Start with a single daily dose of 200-400 mg elemental magnesium from magnesium glycinate. 1
- Increase gradually based on clinical response and tolerance, as some patients may require up to 600 mg daily for therapeutic effect. 1
- Divide doses throughout the day rather than taking a single large dose to optimize absorption. 2
- Administer the larger dose at night when intestinal transit is slowest to maximize absorption. 1
Bioavailability Considerations
Magnesium glycinate is an organic magnesium salt with superior bioavailability compared to inorganic forms like magnesium oxide or hydroxide. 2 Organic magnesium salts (including glycinate, citrate, aspartate, and lactate) demonstrate higher absorption rates and better tolerance. 2
- The bioavailability differences between different organic magnesium compounds (citrate vs. glycinate) are not well established in clinical trials. 2
- Research demonstrates that magnesium bisglycinate produces measurable increases in red blood cell magnesium concentrations. 3
Safety Parameters and Contraindications
Absolute Contraindications
- Avoid all magnesium supplementation in patients with creatinine clearance <20 mL/min due to life-threatening hypermagnesemia risk. 1, 2
- Check renal function before initiating magnesium supplementation. 1
Tolerable Upper Intake Level
- The Tolerable Upper Intake Level is 350 mg/day from supplements alone, though recent evidence suggests higher doses can be consumed without adverse events. 1, 4
- Studies using magnesium intakes of 128-1200 mg/day found no significant differences in diarrhea occurrence between intervention and control groups. 4
Common Side Effects
- Gastrointestinal effects including diarrhea, abdominal distension, and bloating are the most common adverse effects, though typically mild to moderate with magnesium glycinate. 1, 2
- Liquid or dissolvable magnesium products are usually better tolerated than pills. 1, 2
Monitoring Timeline
- Check magnesium levels 2-3 weeks after starting supplementation or after any dose adjustment. 1
- Once on a stable dose, monitor magnesium levels every 3 months. 1
- Monitor more frequently if high gastrointestinal losses, renal disease, or medications affecting magnesium are present. 1
Special Clinical Scenarios
Hypomagnesemia with Concurrent Electrolyte Abnormalities
- When hypomagnesemia coexists with hypokalemia, correct magnesium first, as hypokalemia is resistant to potassium treatment until magnesium is normalized. 1
- Rehydration to correct secondary hyperaldosteronism is crucial before magnesium supplementation in patients with volume depletion. 1
Cardiac Conditions
- For patients with QTc prolongation >500 ms, replete magnesium to >2 mg/dL regardless of baseline level as an anti-torsadogenic countermeasure. 1
- Patients with cardiovascular disease require careful consideration of concurrent medications and electrolyte status, with particular attention to drug interactions such as digoxin and diuretics. 1
Critical Pitfalls to Avoid
- Never assume "mild" renal impairment is safe—magnesium can accumulate with repeated dosing even at creatinine clearance levels of 30-50 mL/min. 1
- Failing to account for acute kidney injury in patients with chronic kidney disease increases risk of magnesium accumulation. 1
- Serum magnesium levels do not accurately reflect total body magnesium status, as less than 1% of magnesium is found in the blood. 1
- Monitor for signs of magnesium toxicity including hypotension, bradycardia, and respiratory depression, particularly in patients with renal impairment. 1